top of page |
Type and details of transgene |
Is the transgene Plasmodium derived |
Transgene: not Plasmodium |
Transgene name | GFPmut2 |
top of page |
Details of the genetic modification |
Inducable system used | No |
Additional remarks inducable system |
|
Type of plasmid/construct | (Linear) plasmid double cross-over |
PlasmoGEM (Sanger) construct/vector used | No |
Modified PlasmoGEM construct/vector used | No
|
Plasmid/construct map |
|
Plasmid/construct sequence |
|
Restriction sites to linearize plasmid |
|
Selectable marker used to select the mutant parasite | hdhfr |
Promoter of the selectable marker | unknown |
Selection (positive) procedure | pyrimethamine |
Selection (negative) procedure | No |
Additional remarks genetic modification | Primers were designed to amplify portions of the pybip promoter consisting of either ~ 300 or ~ 500 bp upstream of the translational start site. Alternatively, promoter regions of pyclag-a, pydynein heavy chain delta (pydd), pylap4 (also called pyccp2), pytrap, pyuis4, or pylisp2 were also designed by selecting 1500–1800 bp upstream of their translational start sites. PCR amplicons were produced by Phusion polymerase (NEB), and were gel extracted (QIAquick Gel Extraction Kit, Qiagen, Cat# 28706), precipitated with ethanol, and ligated into pCR-Blunt (Life Technologies). Promoter sequences were verified via Sanger Sequencing (Penn State Sequencing Core), digested with restriction enzymes, and ligated into pSL0489 to replace the P. berghei eef1a (pbeef1a) promoter. This plasmid backbone contains a Green Fluorescence Protein mutant 2 (GFPmut2) cassette for visualization and a human dihydrofolate reductase (HsDHFR) cassette for drug selection. Plasmids were linearized by cutting between the two arms of the p230p targeting sequences. |
Additional remarks selection procedure | |
top of page |
Other details transgene |
top of page |
Promoter |
Gene Model of Parasite |
PY17X_1354800
|
Gene Model P. falciparum ortholog |
PF3D7_1335900
|
Gene product | thrombospondin-related anonymous protein |
Gene product: Alternative name | TRAP |
Primer information details of the primers used for amplification of the promoter sequence 
Primer information details of the primers used for amplification of the promoter sequence
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
|
|
top of page |
3'-UTR |
Gene Model of Parasite |
PBANKA_0719300
|
Gene product | bifunctional dihydrofolate reductase-thymidylate synthase, putative |
Gene product: Alternative name | dhfr/ts |
Primer information details of the primers used for amplification the 3'-UTR sequences 
Primer information details of the primers used for amplification the 3'-UTR sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
|
|
Insertion/Replacement locus |
Replacement / Insertion | Replacement locus |
Gene Model of Parasite |
PY17X_0306600
|
Gene product | 6-cysteine protein |
Gene product: Alternative name | P230p |
Primer information details of the primers used for amplification of the target sequences
Primer information details of the primers used for amplification of the target sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
Sequence Primer 3 | |
Additional information primer 3 | |
Sequence Primer 4 | |
Additional information primer 4 | |
|
|
top of page |